# OnCo record lenzilumab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/lenzilumab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "lenzilumab" ;
  schema:name "Lenzilumab"@en ;
  schema:alternateName "KB003"@en ;
  schema:description "Lenzilumab is an antibody that soaks up GM-CSF, a growth signal that chronic myelomonocytic leukaemia cells with RAS mutations are unusually sensitive to. It is being tested with azacitidine in this leukaemia."@en ;
  schema:url <https://onco.cc/drugs/lenzilumab/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Lenzilumab> ;
  schema:citation <https://en.wikipedia.org/wiki/Lenzilumab> ;
  onco:status "phase-2" ;
  onco:tag "subtype-drugs-wave" ;
  onco:modality "Humanised anti-GM-CSF monoclonal antibody" ;
  onco:related <https://onco.cc/drugs/azacitidine/> ;
  onco:cancers <https://onco.cc/cancers/cmml/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:companies <https://onco.cc/companies/humanigen/> .